Reviewed by Peptide Treatments Medical Advisory Board
Pemvidutide: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for Pemvidutide.
Back to Pemvidutide overviewData source: Side effect data comes from clinical trials, preclinical research, and anecdotal reports. No FDA-approved labeling exists for this compound.
Reported Side Effects (7 items)
| # | Side Effect |
|---|---|
| 1 | Nausea (common, consistent with GLP-1 class) |
| 2 | Vomiting (common) |
| 3 | Diarrhea (common) |
| 4 | Decreased appetite (common) |
| 5 | Injection site reactions |
| 6 | Theoretical risk of gastroparesis (GLP-1 class effect) |
| 7 | Theoretical risk of thyroid C-cell tumors (GLP-1 class effect) |